Study Demonstrates Antibiotics' Targeting of COVID-19 in Gut Bacteria

New research suggests that antibiotics can effectively target gut bacteria that harbor the virus causing COVID-19, potentially reducing COVID-19-related symptoms and aiding in faster recovery. A study involving 211 participants found that early antibiotic treatment, specifically a combination of amoxicillin and rifaximin within the first 3 days of infection, led to quicker recovery and a lower incidence of long COVID. These findings may influence future vaccine strategies and the treatment of acute COVID-19 infections.